EXCELLENCE BY DESIGN THE FULLY INTELLIGENT END-TO-END SUPPLY CHAIN

DRIVE EFFICIENCY & INNOVATION. PROTECT PRODUCT QUALITY. MITIGATE ENVIRONMENTAL IMPACT.

As costs escalate, environmental legislation tightens and operational complexity increases, the status quo is not an option. Our ability to deliver for our organisations, patients and customers rests on the decisions we take now. But how are we to act? How are we to identify, implement and execute those innovations that will allow us to effectively and efficiently release product and demonstrate long-term regulatory compliance?

Pharma IQ is bringing together senior supply chain, logistics, technology, regulatory and quality leaders from across the industry to demonstrate how they are building a fully intelligent, end-to-end supply chain. Join us in Munich in February 2024 as we discover how to:

• Implement & execute innovation across the supply chain to mitigate environmental impacts & supply chain risks
• Leverage your monitoring data to identify efficiencies and build a fully intelligent & effective end-to-end supply chain
• Bring Logistics & Quality closer together to fast-track validation timelines and shipping lane qualification
• Stay ahead of environmental legislation to bolster long-term regulatory compliance and sustainability
• Harness the power of predictive analytics and supply chain automation to reduce operational expenditure
• Move beyond a reactive approach to protecting product quality & mitigate temperature excursions by design
  

In this short video you can find out more about what to expect at this year's Temperature Control and Logistics Summit. This one-minute video provides a summary of the 2022 top speakers, key themes to be addressed, and what you can look forward to across the 3-event days, to help you address today’s emerging challenges and fully optimise your supply chain processes.

If you would like more information on this summit taking place 7th - 9th June 2022 in Berlin, including the full list of speakers, sessions, sponsors and event opportunities then please view the full event agenda here.

Want to deliver vital therapeutics at the right time, right place and right temperature? Register for the Temperature Control and Logistics Summit here.

Join in the conversation or share this at #TCL

Ahead of the 21st Annual Temperature Control and Logistics Summit 2022, we spoke exclusively to Ruud van der Geer, Associate Director Global Delivery Strategy Team – EMEA Product Handling at MSD, about the increased risks and mitigation strategies for product excursions, the biggest challenges in temperature excursions and the advances in real-time monitoring, to transform the industry’s current capabilities and better serve patient populations.

Download your copy of the report below to access these insights.

The temperature-controlled pharmaceutical supply chain industry is currently under immense pressure, due to an increased demand for vaccines and other critical medical supplies as the healthcare crisis continues. With challenges including the management of complex operating conditions, decreased supply chain capacity, supply chain delays, reduced availability of temperature controlled packaging and more, these insights from MSD are delivered at a critical time to explore the risks and challenges as well as discuss solutions to these ongoing challenges for temperature control and logistics professionals.

The events of the COVID-19 pandemic highlighted and exacerbated vulnerabilities in global pharmaceutical supply chains. Lock-downs, the shut-down of global travel and the mass re-location of workforces have caused pressure across all levels of the supply chain, making the solutions and opportunities of supply chain digitalisation more important now than ever before.

Ahead of the 21st Annual Temperature Control and Logistics (TCL) event, this summary report includes insights from the TCL Digitalisation Exchange about the lessons learned from a year of supply chain disruption and the impact on supply chain digitalisation.

Download the full summary report now >>